(NASDAQ)
24.73
+1.10   (+3.68%)
 
Volume (24h) Market Cap. Day Range 52w Range
200.37K 682.23M 23.52 - 24.75 22.26 - 38.99
Jan-13-21 08:00AM Acutus Medical Reports Preliminary, Unaudited Fourth Quarter and Full Year 2020 ResultsGlobeNewswire
Dec-28-20 04:45AM Acutus Medical to Present at the J.P. Morgan 39th Annual Healthcare ConferenceGlobeNewswire
Dec-17-20 01:43AM Is AFIB A Good Stock To Buy Now?Insider Monkey
Dec-10-20 08:00AM Acutus Medical Announces CE Mark and European Launch of AcQCross™ Transseptal System, a Fully Integrated Family of Transseptal Crossing ProductsGlobeNewswire
Dec-07-20 08:00AM Acutus Medical Launches AcQBlate® Force Sensing Ablation System in EuropeGlobeNewswire
Dec-03-20 12:39PM Is Acutus Medical (AFIB) a Smart Long-term Buy?Insider Monkey
Nov-12-20 04:02AM Steven Mickelsen, MD, Joins Acutus Medical as Chief Translational Science OfficerGlobeNewswire
04:01AM Acutus Medical Reports Third Quarter 2020 ResultsGlobeNewswire
Nov-12-20 03:15AM Acutus Medical Inc to Host Earnings CallACCESSWIRE
Nov-05-20 04:01AM Acutus Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics ForumGlobeNewswire
Oct-29-20 04:01AM Acutus Medical to Announce Third Quarter 2020 Financial ResultsGlobeNewswire
Sep-17-20 04:01AM Acutus Medical Reports Second Quarter 2020 Financial ResultsGlobeNewswire
02:30AM Acutus Medical Inc to Host Earnings CallACCESSWIRE
Sep-08-20 08:30AM Acutus Medical Announces Pulse Field Ablation Program and Initial Pre-Clinical ResultsGlobeNewswire
Sep-03-20 04:01AM Acutus Medical to Announce Second Quarter 2020 Financial ResultsGlobeNewswire
Aug-20-20 04:58AM INTERVIEW: SoCal’s Acutus Medical Rides Biotech IPO WaveIPO-Edge.com
Aug-10-20 04:41AM Acutus Medical Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewswire
Aug-05-20 08:30AM Acutus Medical Announces Pricing of Initial Public OfferingGlobeNewswire
Acutus Medical, Inc., an arrhythmia management company, provides electrophysiology products for the catheter-based treatment of cardiac arrhythmias in the United States and internationally. It offers AcQMap System, an advanced imaging, navigation, and mapping system; AcQMap 3D Imaging and Mapping Catheter, an advanced, non-contact, over-the-wire, and intracardiac device used for standard and complex electrophysiology procedures; and AcQGuide Steerable Sheath, which facilitates the intracardiac placement of diagnostic and/or therapeutic devices. The company was founded in 2011 and is based in Carlsbad, California.
Cap:    |  Volume (24h):